DAIC

MARCH 6, 2024

Food and Drug Administration’s ( FDA ) Breakthrough Device Designation for their ECGvision-TTR Technology for early detection of ATTR-Cardiomyopathy. Food and Drug Administration’s (FDA) Breakthrough Devices Program , which provides patients with timely access to innovative medical devices.

Technology 105

Technology Cardiomyopathy Quality of Life Innovation 105

Journal of Cardiovascular Electrophysiology

DECEMBER 2, 2024

To improve arrhythmogenic cardiomyopathy (ACM) patient care four pillars of ACM research are necessary. Third, preclinical gene studies can improve ACM patient care to determine which vector has the optimal effect in which specific gene for gene therapy.

Cardiomyopathy 40

Cardiomyopathy Sudden Cardiac Death Patient Care Risk Factors 40

DAIC

APRIL 4, 2024

in clinical practice for patients with hypertrophic cardiomyopathy (HCM), a commonly inherited heart disease that often goes undetected. At Viz.ai, we invest in our algorithms to ensure the technology reliably detects suspected conditions, including HCM, and improves patient care and outcomes,” said Molly Madziva Taitt , Ph.D.,

Electrocardiogram 89

Electrocardiogram Cardiomyopathy Hospital Technology 89

DAIC

JUNE 24, 2024

Previously, Kittleson was interim editor-in-chief of the Journal of Heart and Lung Transplantation and helped develop evidence-based cardiomyopathy and heart failure guidelines. She also has served on the board of directors of the Heart Failure Society of America.

Heart Failure 100

Heart Failure Transplant Interventional Cardiology Research 100

DAIC

FEBRUARY 18, 2025

11, 2025 UltraSight, a company committed to enhancing the efficiency and productivity of cardiac ultrasound,recentlyannounced support from Bristol Myers Squibb (BMS) for a study that aims to improve access to echocardiographic assessments for patients with obstructive hypertrophic cardiomyopathy (oHCM).

Ultrasound 52

Ultrasound Echocardiogram Innovation Cardiomyopathy 52

DAIC

APRIL 4, 2024

in clinical practice for patients with hypertrophic cardiomyopathy (HCM), a commonly inherited heart disease that often goes undetected. At Viz.ai, we invest in our algorithms to ensure the technology reliably detects suspected conditions, including HCM, and improves patient care and outcomes,” said Molly Madziva Taitt , Ph.D.,

Electrocardiogram 52

Electrocardiogram Cardiomyopathy Hospital Technology 52

DAIC

FEBRUARY 29, 2024

24 and how those may impact clinical practice and patient care in this deep dive clinical trial session. 12:15 p.m. ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24 More information: www.acc.org If you enjoy this content, please share it with a colleague

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103